Purple Biotech (PPBT) News Today → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free PPBT Stock Alerts $0.81 -0.05 (-5.83%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 8:00 AM | globenewswire.comPurple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic CancerMay 25, 2024 | americanbankingnews.comPurple Biotech Ltd Expected to Earn Q3 2024 Earnings of ($0.13) Per Share (NASDAQ:PPBT)May 22, 2024 | americanbankingnews.comHC Wainwright Reaffirms Buy Rating for Purple Biotech (NASDAQ:PPBT)May 21, 2024 | finanznachrichten.dePurple Biotech Ltd.: Purple Biotech Reports First Quarter 2024 Financial ResultsMay 21, 2024 | msn.comPPBT Stock Earnings: Purple Biotech Beats EPS for Q1 2024May 21, 2024 | globenewswire.comPurple Biotech Reports First Quarter 2024 Financial ResultsApril 25, 2024 | globenewswire.comPurple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual MeetingApril 17, 2024 | investing.comPurple Biotech Ltd (PPBT)March 28, 2024 | finance.yahoo.comPurple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024March 14, 2024 | finanznachrichten.dePurple Biotech Ltd.: Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform TechnologyMarch 14, 2024 | globenewswire.comPurple Biotech Reports Preclinical Proof of Concept for its Tribody Platform TechnologyMarch 5, 2024 | investorplace.comPPBT Stock Earnings: Purple Biotech Meets EPS for Q4 2023March 5, 2024 | finanznachrichten.dePurple Biotech Ltd.: Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 5, 2024 | globenewswire.comPurple Biotech Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 3, 2024 | investing.comPurple Biotech ADR (PPBT) Earnings Dates & ReportsFebruary 27, 2024 | markets.businessinsider.comBuy Rating Justified by Promising Phase 1 Results of Purple Biotech’s NT219 in SCCHN TreatmentFebruary 27, 2024 | morningstar.comPurple Biotech Ltd ADRFebruary 27, 2024 | globenewswire.comPurple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024February 22, 2024 | wsj.comPurple Biotech Ltd. ADRFebruary 15, 2024 | morningstar.comPurple Biotech Ltd ADR PPBTFebruary 13, 2024 | finance.yahoo.comPurple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 TrialFebruary 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Sanofi (OtherSNYNF)February 1, 2024 | msn.comPurple Biotech stock climbs 9% on Phase 2 study updateFebruary 1, 2024 | finance.yahoo.comPurple Biotech Reaches Recommended Phase 2 Dose for NT219December 20, 2023 | finance.yahoo.comPurple Biotech Appoints Dr. Yael Margolin to its Board of DirectorsDecember 14, 2023 | finanznachrichten.dePurple Biotech Ltd.: Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer TrialDecember 14, 2023 | finance.yahoo.comPurple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer TrialNovember 22, 2023 | markets.businessinsider.comPromising Clinical Trial Results and Accelerated Enrollment Boost Purple Biotech’s Buy RatingNovember 21, 2023 | finance.yahoo.comPurple Biotech Reports Third Quarter 2023 Financial ResultsNovember 2, 2023 | finance.yahoo.comPurple Biotech Fortifies NT219 Patent ProtectionOctober 19, 2023 | finance.yahoo.comPurple Biotech Announces Closing of $5 Million Registered Direct OfferingOctober 17, 2023 | marketwatch.comPurple Biotech Shares Drop 16% After Direct Offering PricesOctober 17, 2023 | msn.comPurple Biotech announces $5M direct offering to fund oncology therapeutic candidatesOctober 17, 2023 | finance.yahoo.comPurple Biotech Announces $5 Million Registered Direct OfferingOctober 6, 2023 | finance.yahoo.comPurple Biotech Reports Potential Biomarker Data Support CM24’s Mechanism of ActionOctober 3, 2023 | finance.yahoo.comPurple Biotech Reports Positive Interim and Preliminary Results from NT219 Phase 1/2 Study in R/M Head & Neck CancerSeptember 21, 2023 | finance.yahoo.comPurple Biotech to Present New CM24 Pancreatic Cancer Biomarker Data at AACR Special Conference on September 28, 2023August 30, 2023 | markets.businessinsider.comH.C. Wainwright Remains a Buy on Purple Biotech (PPBT)August 22, 2023 | finanznachrichten.dePurple Biotech Ltd.: Purple Biotech Reports Second Quarter 2023 Financial ResultsJuly 11, 2023 | msn.comIsrael's Purple reports encouraging early data for pancreatic cancer drugJuly 11, 2023 | finance.yahoo.comPurple Biotech Reports Positive Results of CM24 Dose Escalation in Advanced Pancreatic Cancer PatientsMay 17, 2023 | finanznachrichten.dePurple Biotech Ltd.: Purple Biotech Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 16, 2023 | msn.comPurple Biotech: Q1 Earnings InsightsMay 16, 2023 | finance.yahoo.comPurple Biotech Reports First Quarter 2023 Financial Results and Provides Business UpdateApril 25, 2023 | finance.yahoo.comPurple Biotech Debuts Scientific Advisory BoardApril 19, 2023 | finance.yahoo.comPurple Biotech Reports New Preclinical Data on Potential of NT219 to Re-sensitize Resistant Tumors to Immune Checkpoint InhibitorsApril 18, 2023 | finance.yahoo.comPurple Biotech to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual ConferenceMarch 24, 2023 | marketwatch.comPurple Biotech Taps Israel as Acting CEO With Efron on Medical LeaveMarch 24, 2023 | finance.yahoo.comPurple Biotech Reports Temporary Medical Leave of CEO Gil EfronMarch 16, 2023 | finance.yahoo.comPurple Biotech Reports Biomarker Data from CM24 Phase 1 Dose Escalation Study Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. PPBT Media Mentions By Week PPBT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PPBT News Sentiment▼0.110.76▲Average Medical News Sentiment PPBT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PPBT Articles This Week▼30▲PPBT Articles Average Week Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Anixa Biosciences News Today Cue Biopharma News Today Spero Therapeutics News Today Hookipa Pharma News Today PyroGenesis Canada News Today Genelux News Today Aclaris Therapeutics News Today Annovis Bio News Today vTv Therapeutics News Today Aileron Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PPBT) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
